Cargando…
Mucormycosis – resurgence of a deadly opportunist during COVID-19 pandemic: Four case reports
BACKGROUND: Coronavirus disease 2019 (COVID-19) patients who suffer severe infection or comorbidities have an increased risk of developing fungal infections. There is a possibility that such infections are missed or misdiagnosed, in which case patients may suffer higher morbidity and mortality. COVI...
Autores principales: | Upadhyay, Shalini, Bharara, Tanisha, Khandait, Manisha, Chawdhry, Ankit, Sharma, Bharat Bhushan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717511/ https://www.ncbi.nlm.nih.gov/pubmed/35071564 http://dx.doi.org/10.12998/wjcc.v9.i36.11338 |
Ejemplares similares
-
Resurgence of mucormycosis during COVID-19 pandemic
por: Ali, Kamran, et al.
Publicado: (2022) -
Current Understanding, Knowledge Gaps and a Perspective on the Future of COVID-19 Infections: A Systematic Review
por: Chakravarti, Anita, et al.
Publicado: (2020) -
Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review
por: Karkhur, Samendra, et al.
Publicado: (2023) -
Resurgence of Global Opportunistic Multidrug-resistant Stenotrophomonas maltophilia
por: Gupta, Pradheer, et al.
Publicado: (2018) -
Mucormycosis: An opportunistic pathogen during COVID-19
por: Mahalaxmi, Iyer, et al.
Publicado: (2021)